title: Telangiectasia macularis eruptive perstans (TMEP) in childhood: a case report and literature review.
authors: S
authors: S
authors: Leonardi
authors: G
authors: G
authors: Vitaliti
authors: A D
authors: AD
authors: Praticò
authors: M
authors: M
authors: La Rosa
mesh_terms: D000085:Acetates / Q000008:administration & dosage*; D002196:Capillaries / Q000473:pathology; D002675:Child, Preschool; D003521:Cyclopropanes; D003937:Diagnosis, Differential; D004108:Dilatation, Pathologic / Q000209:etiology; D018572:Disease-Free Survival; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood; D007223:Infant; D020024:Leukotriene Antagonists / Q000008:administration & dosage*; D008297:Male; D008407:Mast Cells / Q000187:drug effects* / Q000473:pathology; D034701:Mastocytosis, Cutaneous / Q000209:etiology; D011804:Quinolines / Q000008:administration & dosage*; D012867:Skin / Q000098:blood supply / Q000473:pathology; D013440:Sulfides; D013684:Telangiectasis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*
chemical_list: D000085:Acetates; D003521:Cyclopropanes; D020024:Leukotriene Antagonists; D011804:Quinolines; D013440:Sulfides; D007073:Immunoglobulin E; C093875:montelukast